[1]
I. L. Tarigan and K. Arum, “Modulation of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in receptor, innate immunity and drug antiviral candidate”, J. Teknol. Laboratorium, vol. 9, no. 1, pp. 1–12, Jun. 2020.